Advs. Barry Levenfeld, Ben Sandler, Evan Schendler, Alona Toledano, Ofir Levy, Shay Fahima, Yoheved Novogroder Shoshan, Daniel Green, Miriam Friedmann, Tali Har-Oz and the interns Itamar Ben David, Hadar Stein and Elad Cohen represented the med-tech giant Stryker in the acquisition of Orthospace Ltd, an Israeli company that has developed a device for treating serious shoulder pain, for $220 million.
Yigal Arnon & Co. in cooperation with IATI (Israel Advanced Technology Industries) invite Hi-Tech & Life Science Start-ups to join us in the event: “The Ins-and-Outs of the Due Diligence Process in Investment Transactions”, October 23, 2013, Yigal Arnon & Co. offices.
Advocates Barry Levenfeld, Harry Kirsh, Yuval Shalhevet, Zohar Nevo and Noam Enk represents the winning bidding consortium, consisting of Johnson & Johnson, Takeda Pharmaceuticals (the first Japanese Pharmaceutical Company to invest in Israel) and the healthcare fund OrbiMed Israel, for the establishment of an OCS-supported biotechnological incubator intended to encourage the creation and support of pharmaceutical and medical device companies.
Advs. Barry Levenfeld, Eric Spindel, Avigail Frisch and Noam Enk represented Aegis for Alcobra Ltd.'s initial public offering on Nasdaq. Alcobra Ltd., headquartered in Israel, is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug to treat Attention Deficit Hyperactivity Disorder.
Advocates Barry Levenfeld, Ben Sandler, Harry Kirsh, Avigail Frisch and Zohar Nevo represented Stryker, an U.S.-based leader in worldwide orthopedic medical technology in the acquisition of the Israeli company Surpass Medical, which develops and commercializes next-generation flow diversion technology to treat brain aneurysms, for $135 million.
Barry Levenfeld chaired the session on Merger and Acquisitions of Life Science and Technology Companies in the International Bar Association Conference on "The Globalization of Knowledge-Based Industries" that took place in Tel Aviv, at the Hilton Hotel, on February 9-11.